Skip to main content
Signal8

Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

$ZURAPress releaseMay 14, 2026, 7:30 AM ETRead the release

Zura Bio granted an option to purchase up to 600,000 Class A Ordinary Shares to Muzammil Mustufa, the company's new Chief Business Officer. The option has an exercise price of $4.80 per share, which is equal to the closing price on May 13, 2026. The option will vest over four years, with one-fourth vesting on the one-year anniversary of the vesting commencement date and the remaining shares vesting in equal quarterly installments.

Key figures

Offering Price
4.8
Shares Offered
600000

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.